Αρχειοθήκη ιστολογίου

Πέμπτη 28 Σεπτεμβρίου 2017

Resistance development to mycobacterum tuberculosis is manageable in hidradentis suppurativa. Response to Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?

Abstract

We read the letter by Mendes-Bastos et al. with concern.1 Simply testing patients for latent tuberculosis solves the problem, and the authors did not mention that rifampin is an acceptable monotherapy for latent tuberculosis.2 Hidradentitis suppurativa has the highest impact on quality of life of all dermatological diseases,3 and clindamycin and rifampin are a cornerstones of frequently failing therapy regimes.3 At the same time drug-resistant tuberculosis is a tremendous public health problem, particularly in China, the former Soviet Union, and India.

This article is protected by copyright. All rights reserved.



http://ift.tt/2xHnK45

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου